Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
KUNLUN ENERGY
00135
HK Stock MarketDetailed Quotes
CI FIN TECH GP (08029)
- 0.870
- -0.060-6.45%
Market Closed May 20 15:38 CST
243.67MMarket Cap-7.13P/E (TTM)
0.930High0.870Low80.00KVolume0.930Open0.930Prev Close71.50KTurnover0.03%Turnover RatioLossP/E (Static)280.08MShares1.59052wk High-2.62P/B243.67MFloat Cap0.41052wk Low--Dividend TTM280.08MShs Float18.833Historical High--Dividend LFY6.45%Range %0.320Historical Low0.894Avg Price5000Lot Size--Div Yield TTM--Div Yield LFY
CI FIN TECH GP (08029) Cash Flow
All
YOY
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -228.25%-46.77M | ---- | 88.07%-14.25M | ---- | -13.50%-119.46M | ---- | -83.20%-105.25M | ---- | 4.61%-57.45M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -37.58%-432K | ---- | 33.76%-314K | ---- | -23,600.00%-474K | ---- | 97.70%-2K | ---- | 78.25%-87K |
| Impairment and provisions: | ---- | 167.87%6.84M | ---- | -120.30%-10.08M | ---- | -30.98%49.64M | ---- | 1,217.37%71.93M | ---- | -128.97%-6.44M |
| -Impairment of property, plant and equipment (reversal) | ---- | --1.7M | ---- | ---- | ---- | -59.38%13.6M | ---- | --33.47M | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | --900K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | -64.74%177K | ---- | 161.14%502K | ---- | -388.07%-821K | ---- | 112.66%285K | ---- | ---2.25M |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -35.71%18.43M |
| -Other impairments and provisions | ---- | 138.41%4.06M | ---- | -128.70%-10.58M | ---- | -3.42%36.86M | ---- | 268.77%38.17M | ---- | -250.62%-22.62M |
| Revaluation surplus: | ---- | -95.50%204K | ---- | 441.58%4.53M | ---- | 273.29%837K | ---- | -102.16%-483K | ---- | 175.54%22.32M |
| -Fair value of investment properties (increase) | ---- | ---- | ---- | 690.62%4.28M | ---- | 70.70%-725K | ---- | ---2.47M | ---- | ---- |
| -Other fair value changes | ---- | -18.73%204K | ---- | -83.93%251K | ---- | -21.55%1.56M | ---- | -91.08%1.99M | ---- | 175.54%22.32M |
| Asset sale loss (gain): | ---- | 102.05%167K | ---- | -14,453.57%-8.15M | ---- | ---56K | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---8.15M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | --167K | ---- | ---- | ---- | ---56K | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | 708.23%1.28M | ---- | -98.00%158K | ---- | 97.33%7.9M | ---- | -40.07%4M | ---- | -11.92%6.68M |
| -Amortization of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -44.68%104K | ---- | 14.63%188K |
| Financial expense | ---- | -13.10%14.97M | ---- | 12.07%17.22M | ---- | -15.53%15.37M | ---- | -11.38%18.19M | ---- | -23.20%20.53M |
| Special items | ---- | -87.91%612K | ---- | -82.00%5.06M | ---- | 1,060.27%28.14M | ---- | -122.06%-2.93M | ---- | 1,210.45%13.28M |
| Operating profit before the change of operating capital | ---- | -297.95%-23.13M | ---- | 67.90%-5.81M | ---- | -24.48%-18.11M | ---- | -1,149.91%-14.55M | ---- | -142.90%-1.16M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | --252K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Accounts receivable (increase)decrease | ---- | -136.68%-1.77M | ---- | 371.73%4.82M | ---- | -110.66%-1.77M | ---- | -8.50%16.63M | ---- | 254.67%18.17M |
| Accounts payable increase (decrease) | ---- | 99.92%-8K | ---- | -77.94%-9.92M | ---- | 91.18%-5.57M | ---- | 19.22%-63.15M | ---- | -238.56%-78.17M |
| prepayments (increase)decrease | ---- | 98.95%-28K | ---- | -160.96%-2.67M | ---- | 215.85%4.38M | ---- | -155.09%-3.78M | ---- | 423.74%6.86M |
| Special items for working capital changes | ---- | -85.16%3.88M | ---- | -52.18%26.16M | ---- | -16.68%54.71M | ---- | -51.31%65.67M | ---- | 751.74%134.86M |
| Cash from business operations | ---- | -265.32%-20.8M | ---- | -62.59%12.58M | ---- | 4,011.74%33.63M | ---- | -98.98%818K | ---- | 236.71%80.56M |
| Other taxs | ---- | ---193K | ---- | ---- | ---- | 813.28%2.63M | ---- | 83.31%-369K | ---- | -207.43%-2.21M |
| Special items of business | 43.27%-5.13M | ---- | -406.55%-9.04M | ---- | -86.75%2.95M | ---- | 159.93%22.24M | ---- | -186.83%-37.12M | ---- |
| Net cash from operations | 43.27%-5.13M | -266.85%-20.99M | -406.55%-9.04M | -65.31%12.58M | -86.75%2.95M | 7,977.06%36.27M | 159.93%22.24M | -99.43%449K | -186.83%-37.12M | 201.54%78.35M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 37.58%432K | ---- | -33.76%314K | ---- | 23,600.00%474K | ---- | -97.70%2K | ---- | -76.29%87K |
| Sale of fixed assets | ---- | ---- | ---- | --8.15M | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | ---- | -145.47%-2.39M | ---- | -1,004.55%-972K | ---- | 99.54%-88K | ---- | -489.46%-19.07M | ---- | -11.67%-3.24M |
| Selling intangible assets | ---- | ---- | ---- | ---- | ---- | --58K | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | --519K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | --36.6M | --32.16M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items in the investment business | ---- | --519K | 102.31%17K | ---- | -36,950.00%-737K | ---- | -96.72%2K | ---- | 103.79%61K | ---- |
| Net cash from investment operations | ---- | 369.37%35.17M | 4,536.36%32.7M | 1,587.39%7.49M | -36,950.00%-737K | 102.33%444K | -96.72%2K | -505.69%-19.07M | 103.79%61K | 20.36%-3.15M |
| Net cash before financing | -121.67%-5.13M | -29.40%14.17M | 970.06%23.66M | -45.32%20.07M | -90.06%2.21M | 297.17%36.71M | 160.04%22.25M | -124.76%-18.62M | -190.08%-37.06M | 241.35%75.2M |
| Cash flow from financing activities | ||||||||||
| Refund | ---- | ---2.08M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuing shares | ---- | ---- | ---- | --1.38M | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | ---- | ---223K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -12.30%-3.17M |
| Issuance expenses and redemption of securities expenses | ---- | 26.31%-26.53M | -20.00%-12M | 32.08%-36M | 66.67%-10M | ---53M | ---30M | ---- | ---- | -755.56%-77M |
| Other items of the financing business | 484.26%4.15M | ---- | 2.00%-1.08M | ---- | ---1.1M | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | 131.73%4.15M | 13.85%-31.81M | -17.82%-13.08M | 32.73%-36.93M | 64.37%-11.1M | -2,173.17%-54.9M | -2,485.64%-31.16M | 97.08%-2.42M | 93.30%-1.21M | -509.97%-82.61M |
| Effect of rate | 66.67%-34K | 31.81%-1.22M | -256.92%-102K | -63.33%-1.8M | 104.88%65K | -206.98%-1.1M | -109.45%-1.33M | -109.34%-358K | 258.52%14.11M | 143.08%3.83M |
| Net Cash | -109.24%-977K | -4.68%-17.64M | 218.99%10.58M | 7.33%-16.85M | 0.22%-8.89M | 13.53%-18.19M | 76.71%-8.91M | -183.69%-21.03M | -265.25%-38.26M | -187.37%-7.41M |
| Begining period cash | -37.97%29.53M | -28.15%47.6M | -28.15%47.6M | -22.55%66.25M | -22.55%66.25M | -20.01%85.54M | -20.01%85.54M | -3.24%106.93M | -3.24%106.93M | -0.02%110.51M |
| Cash at the end | -50.90%28.52M | -39.63%28.73M | 1.14%58.08M | -28.15%47.6M | -23.73%57.42M | -22.55%66.25M | -9.04%75.29M | -20.01%85.54M | -33.65%82.77M | -3.24%106.93M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unaudited opinion |
| Auditor | -- | Bai Chun Accounting Firm Limited | -- | Bai Chun Accounting Firm Limited | -- | Bai Chun Accounting Firm Limited | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"